Benchmark posted increased profits and revenues for the first half of 2019 driven by growth in genetics, animal health and knowledge services.
Its adjusted earnings before interest, tax, demortization and amortization (EBITDA) increased by 25 percent to 7.5 million on a 3.4 percent increase in revenue to 78.3 million.
The improvement was made despite lower revenues in its advanced nutrition business, which was dragged down by a weak global shrimp market.
